EVRY, France--(BUSINESS WIRE)--Regulatory News :
Global Bioenergies (Paris:ALGBE) (Alternext Paris: ALGBE) carries out a new draw down on the equity line signed on May 16th, 2014 with Yorkville Advisors.
Global Bioenergies issues 2,600 new shares individually priced at 38.78 euros as part of this new draw down. As per the signed agreement, the issued price of these new shares includes a 5% discount on the lowest weighted average price of ordinary shares traded during the previous five consecutive trading days.
The funds will be distributed amongst the Company’s programs.
The 2,600 new shares, which result in an equity dilution inferior to 0.1%, will be freely tradable on Alternext Paris and assimilated with the existing 2,757,156 shares.
About GLOBAL BIOENERGIES
Global Bioenergies is one of the few companies worldwide, and the only
one in Europe, that is developing a Global Bioenergies is one of the few
companies worldwide, and the only one in Europe, that is developing a
process to convert renewable resources into hydrocarbons through
fermentation. The Company initially focused its efforts on the
production of isobutene, one of the most important petrochemical
building blocks that can be converted into fuels, plastics, organic
glass and elastomers. Global Bioenergies continues to improve the yield
of its process and is actively entering the industrial pilot testing
phase. The company recently replicated this success to propylene and
butadiene and is also looking to continue with other members of the
gaseous olefins family, key molecules at the heart of petrochemical
Global Bioenergies is listed on Alternext, Euronext Paris (FR0011052257 – ALGBE)
Should you like to be kept informed, subscribe to our news feed on
Follow us on Twitter: @GlobalBioenergi